
Respiratory syncytial virus (RSV) has traditionally been thought of as a disease of infants. As many as 80,000 babies under age five are hospitalized annually in the U.S. with RSV, mostly in the winter, and some 300 die. Until very recently, there was little that could be done to prevent RSV. A monoclonal antibody […] Read more »






